Application of ultrasound-guided biopsy and percutaneous radiofrequency ablation in 2 cases with phosphaturic mesenchymal tumor and literature review

Clin Hemorheol Microcirc. 2021;77(1):61-69. doi: 10.3233/CH-200921.

Abstract

Tumor-induced osteomalacia (TIO) is a vanishingly rare paraneoplastic syndrome which is usually caused by phosphaturic mesenchymal tumors (PMTs). The conventional treatment for PMTs is total resection, and ultrasound-guided radiofrequency ablation (RFA) can also be used for the treatment of PMTs patients, especially for patients in whom complete resection may lead to serious complications. We report two cases with PMT who presented syndrome with progressive musculoskeletal complaints and performed ultrasound-guided biopsy and RFA. Ultrasound-guided RFA, which is a safe and effective minimally invasive treatment option, appears to be a valuable alternative to surgery for patients presenting with PMT. We are the first reported case of RFA guided by ultrasonography in the treatment of PMT.

Keywords: Tumor-induced osteomalacia; oncogenic osteomalacia; phosphaturic mesenchymal tumor; radiofrequency ablation; ultrasound.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adult
  • Catheter Ablation / methods*
  • Humans
  • Image-Guided Biopsy / methods*
  • Male
  • Mesenchymoma / diagnostic imaging*
  • Osteomalacia / diagnostic imaging*
  • Paraneoplastic Syndromes / diagnostic imaging*
  • Radiofrequency Ablation / methods*
  • Treatment Outcome
  • Ultrasonography / methods*
  • Ultrasonography, Interventional / adverse effects

Supplementary concepts

  • Oncogenic osteomalacia